首页> 外文期刊>Medicine. >The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysis
【24h】

The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysis

机译:GSTA1,GSTM1,GSTP1和GSTT1基因多态性与膀胱癌易感性的关系:荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background:Previous studies have investigated the relationship between GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and bladder cancer (BCa) susceptibility, respectively, but the results remain inconsistent. So, we conducted this meta-analysis including 79 case-control studies to explore such relationships.Methods:We searched PubMed, EMBASE, Cochrane library, Web of Science, and CNKI for relevant available studies. The pooled odds ratios (ORs) with 95% confidence intervals (CIs) were implemented to evaluate the intensity of associations. Publication bias was estimated using Begg funnel plots and Egger regression test. To assess the stability of the results, we used sensitivity analysis with the method of calculating the results again by omitting 1 single study each time. Between-study heterogeneity was tested using the I-2 statistic.Results:No significant association between GSTA1 polymorphism and BCa susceptibility (OR=1.05, 95% CI 0.83-1.33) was noted. Besides, meaningful association between individuals who carried the GSTM1 null genotype and increased BCa risk was detected (OR=1.39, 95%CI 1.28-1.51). When stratified by ethnicity, significant difference was found in both Caucasian (OR=1.39, 95% CI 1.23-1.58) and Asian populations (OR=1.45, 95% CI 1.31-1.61). Moreover, in the subgroup analysis by source of controls (SOC), the results were significant in both hospital-based control groups (OR=1.49, 95% CI 1.35-1.64) and population-based control groups (OR=1.21, 95% CI=1.07-1.37). Additionally, the analysis revealed no significant association between GSTP1 polymorphism and BCa risk (OR=1.07, 95% CI 0.96-1.20). What is more, significant associations between GSTT1 polymorphism and BCa susceptibility were discovered (OR=1.11, 95% CI 1.00-1.22). In the subgroup analysis by ethnicity, significant associations between GSTT1 null genotype and BCa risk were observed only in Caucasians (OR=1.25, 95% CI 1.09-1.44). Furthermore, when stratified by SOC, no obvious relationship was found between the GSTT1 null genotype polymorphism with hospital-based population (OR=1.11, 95% CI 0.97-1.28) or population-based population (OR=1.10, 95% CI 0.96-1.27).Conclusion:This study suggested that GSTM1 null genotype and GSTT1 null genotype might be related to higher BCa risk, respectively. However, no associations were observed between GSTA1 or GSTP1 polymorphisms and BCa susceptibility.
机译:背景:先前的研究分别研究了GSTA1,GSTM1,GSTP1和GSTT1多态性与膀胱癌(BCa)易感性之间的关系,但结果仍然不一致。因此,我们进行了这项包括79个病例对照研究的荟萃分析,以探讨这种关系。方法:我们在PubMed,EMBASE,Cochrane图书馆,Web of Science和CNKI中进行了相关研究。实施具有95%置信区间(CI)的合并比值比(OR)来评估关联强度。使用Begg漏斗图和Egger回归测试估计出版偏倚。为了评估结果的稳定性,我们使用敏感性分析,并通过每次省略1个单项研究来再次计算结果。结果:没有发现GSTA1多态性与BCa敏感性之间存在显着相关性(OR = 1.05,95%CI 0.83-1.33)。此外,检测到携带GSTM1无效基因型的个体与BCa风险增加之间的有意义的关联(OR = 1.39,95%CI 1.28-1.51)。当按种族进行分层时,在白种人(OR = 1.39,95%CI 1.23-1.58)和亚洲人口(OR = 1.45,95%CI 1.31-1.61)中都存在显着差异。此外,在按控制源(SOC)进行的亚组分析中,基于医院的对照组(OR = 1.49,95%CI 1.35-1.64)和基于人群的对照组(OR = 1.21,95%)的结果均显着CI = 1.07-1.37)。此外,分析显示GSTP1多态性与BCa风险之间无显着关联(OR = 1.07,95%CI 0.96-1.20)。此外,还发现了GSTT1多态性与BCa敏感性之间的显着相关性(OR = 1.11,95%CI 1.00-1.22)。在按种族进行的亚组分析中,仅在白种人中观察到GSTT1无效基因型与BCa风险之间的显着关联(OR = 1.25,95%CI 1.09-1.44)。此外,当通过SOC分层时,未发现GSTT1无效基因型多态性与医院人群(OR = 1.11,95%CI 0.97-1.28)或人群人群(OR = 1.10,95%CI 0.96-6.2)之间存在明显的相关性。 1.27)。结论:这项研究表明,GSTM1无效基因型和GSTT1无效基因型可能分别与较高的BCa风险有关。但是,没有观察到GSTA1或GSTP1多态性与BCa敏感性之间的关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号